🇺🇸 FDA
Patent

US 8765685

Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)

granted A61KA61K2039/505A61K38/00

Quick answer

US patent 8765685 (Methods for treating edema by administering a Soluble Hyaluronidase Glycoprotein (sHASEGP)) held by HALOZYME, INC. expires Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Jul 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 26 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61K38/00, A61K38/47, A61K39/395